SCHEDULE: MDxHealth SA: Lytton and Foundation Disclose Major Stake

Laurence W. Lytton and the Lytton-Kambara Foundation have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 31.6% of MDxHealth SA's ordinary shares.

Summary

• Laurence W. Lytton and the Lytton-Kambara Foundation have filed an amendment to their Schedule 13G, reporting their beneficial ownership of MDxHealth SA ordinary shares.
• Laurence W. Lytton individually holds 18,558,988 shares, representing 19.5% of the outstanding ordinary shares.
• The Lytton-Kambara Foundation holds 11,583,098 shares, representing 12.1% of the outstanding ordinary shares.
• The total combined beneficial ownership reported is 30,142,086 shares, equating to 31.6% of the outstanding ordinary shares.
• This filing is an amendment (Amendment No. 4) and indicates a joint filing agreement between Laurence W. Lytton and the Lytton-Kambara Foundation.
• The percentages are calculated based on 95,417,382 Ordinary Shares outstanding as of August 13, 2026, as reported in a Form 6-K filed by the Issuer on August 13, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant ownership stake without immediate strategic implications.

Positives

• Significant combined ownership stake of 31.6% by Laurence W. Lytton and the Lytton-Kambara Foundation, indicating substantial investor interest.
• Clear disclosure of ownership percentages and shareholdings, providing transparency to the market.

Negatives

• The filing does not provide details on the purpose of this ownership stake beyond routine reporting, leaving strategic intent unclear.

Risks

• Potential for future changes in control or influence if the reporting persons decide to act in concert beyond the current joint filing agreement.
• Market speculation regarding the intentions behind the significant combined stake could lead to increased share price volatility.

Future Outlook

The filing itself does not contain forward-looking statements or specific future guidance from the company. It is a disclosure of ownership.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders to report stakes exceeding 5%. The substantial combined stake in MDxHealth SA by Laurence W. Lytton and the Lytton-Kambara Foundation suggests a significant level of confidence or strategic interest in the company's sector, which is typically related to diagnostics or healthcare technology.

Stakeholder Impact

• Shareholders: Increased transparency regarding major ownership stakes, potentially influencing market perception and trading activity.
• Management: May face increased scrutiny or engagement from significant shareholders regarding company strategy and performance.

Next Steps

• Continued monitoring of MDxHealth SA's performance and any further disclosures from Laurence W. Lytton and the Lytton-Kambara Foundation.
• Potential for future filings if ownership levels change significantly or if strategic actions are taken.

Key Dates

Keywords

MDxHealth SA, Schedule 13G, Beneficial Ownership, Ordinary Shares, Laurence W. Lytton, Lytton-Kambara Foundation, Shareholder Disclosure, Investment Holding